Skip to main content
Clinical Trials/JPRN-UMIN000047026
JPRN-UMIN000047026
Completed
未知

Analysis of factors associated with blood pressure reduction and serum potassium elevation in hypertensive patients treated with esaxerenone (CS-3150) -Integrated analysis from CS-3150 phase 3 studies- - Analysis of factors associated with blood pressure reduction and serum potassium elevation in hypertensive patients treated with esaxerenone (CS-3150)

Daiichi Sankyo Co., Ltd.0 sites1,472 target enrollmentMarch 1, 2022
ConditionsHypertension

Overview

Phase
未知
Intervention
Not specified
Conditions
Hypertension
Sponsor
Daiichi Sankyo Co., Ltd.
Enrollment
1472
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2022
End Date
March 1, 2022
Last Updated
2 years ago
Study Type
Others,meta-analysis etc
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not applicable

Outcomes

Primary Outcomes

Not specified

Similar Trials